Compare Abbott India with ALEMBIC PHARMA - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ABBOTT INDIA vs ALEMBIC PHARMA - Comparison Results

ABBOTT INDIA     Change

Formerly known as Knoll Pharmaceuticals Limited, Abbott India Limited (AIL) is a subsidiary of Abbott Capital India Limited in which the latter holds about 69% stake. It is involved in the discovery, development, manufacture and marketing of pharmace... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ABBOTT INDIA ALEMBIC PHARMA ABBOTT INDIA/
ALEMBIC PHARMA
 
P/E (TTM) x 46.9 16.6 283.0% View Chart
P/BV x 15.3 6.6 232.6% View Chart
Dividend Yield % 0.4 0.6 77.5%  

Financials

 ABBOTT INDIA   ALEMBIC PHARMA
EQUITY SHARE DATA
    ABBOTT INDIA
Mar-19
ALEMBIC PHARMA
Mar-19
ABBOTT INDIA/
ALEMBIC PHARMA
5-Yr Chart
Click to enlarge
High Rs8,834664 1,330.4%   
Low Rs5,458412 1,323.4%   
Sales per share (Unadj.) Rs1,731.1208.7 829.4%  
Earnings per share (Unadj.) Rs211.931.0 683.7%  
Cash flow per share (Unadj.) Rs219.937.1 592.5%  
Dividends per share (Unadj.) Rs65.005.50 1,181.8%  
Dividend yield (eoy) %0.91.0 89.0%  
Book value per share (Unadj.) Rs945.2144.2 655.4%  
Shares outstanding (eoy) m21.25188.52 11.3%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x4.12.6 160.1%   
Avg P/E ratio x33.717.4 194.2%  
P/CF ratio (eoy) x32.514.5 224.1%  
Price / Book Value ratio x7.63.7 202.6%  
Dividend payout %30.717.7 172.9%   
Avg Mkt Cap Rs m151,848101,461 149.7%   
No. of employees `0003.5NA-   
Total wages/salary Rs m4,3567,467 58.3%   
Avg. sales/employee Rs Th10,555.5NM-  
Avg. wages/employee Rs Th1,249.9NM-  
Avg. net profit/employee Rs Th1,292.2NM-  
INCOME DATA
Net Sales Rs m36,78639,347 93.5%  
Other income Rs m1,13394 1,207.8%   
Total revenues Rs m37,91939,441 96.1%   
Gross profit Rs m6,0478,736 69.2%  
Depreciation Rs m1691,152 14.7%   
Interest Rs m23184 12.2%   
Profit before tax Rs m6,9897,493 93.3%   
Minority Interest Rs m011 0.0%   
Prior Period Items Rs m0-93 0.0%   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m2,4851,568 158.5%   
Profit after tax Rs m4,5035,844 77.1%  
Gross profit margin %16.422.2 74.0%  
Effective tax rate %35.620.9 170.0%   
Net profit margin %12.214.9 82.4%  
BALANCE SHEET DATA
Current assets Rs m27,61019,577 141.0%   
Current liabilities Rs m8,56914,896 57.5%   
Net working cap to sales %51.811.9 435.1%  
Current ratio x3.21.3 245.2%  
Inventory Days Days6090 67.1%  
Debtors Days Days2745 60.4%  
Net fixed assets Rs m1,05727,097 3.9%   
Share capital Rs m213377 56.4%   
"Free" reserves Rs m19,87326,811 74.1%   
Net worth Rs m20,08627,188 73.9%   
Long term debt Rs m04,993 0.0%   
Total assets Rs m29,40947,778 61.6%  
Interest coverage x311.641.7 747.2%   
Debt to equity ratio x00.2 0.0%  
Sales to assets ratio x1.30.8 151.9%   
Return on assets %15.412.6 122.0%  
Return on equity %22.421.5 104.3%  
Return on capital %34.923.6 147.9%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m36919,453 1.9%   
Fx outflow Rs m4,9186,065 81.1%   
Net fx Rs m-4,54913,388 -34.0%   
CASH FLOW
From Operations Rs m4,9918,120 61.5%  
From Investments Rs m-2,570-7,556 34.0%  
From Financial Activity Rs m-1,428590 -241.9%  
Net Cashflow Rs m9931,153 86.1%  

Share Holding

Indian Promoters % 0.0 74.1 -  
Foreign collaborators % 75.0 0.0 -  
Indian inst/Mut Fund % 7.9 2.9 272.4%  
FIIs % 0.1 9.1 1.1%  
ADR/GDR % 0.0 0.0 -  
Free float % 17.1 13.9 123.0%  
Shareholders   18,270 49,328 37.0%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ABBOTT INDIA With:   NATCO PHARMA  STRIDES PHARMA SCIENCE  FDC  TORRENT PHARMA  FRESENIUS KABI ONCO.  

Compare ABBOTT INDIA With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Indigo Paints IPO, India's Crude Oil Production in December, and Buzzing Stocks Today(Pre-Open)

Indian share markets witnessed a sharp sell-off during closing hours yesterday and ended lower.

Related Views on News

ALEMBIC PHARMA Announces Quarterly Results (3QFY21); Net Profit Up 13.8% (Quarterly Result Update)

Jan 19, 2021 | Updated on Jan 19, 2021

For the quarter ended December 2020, ALEMBIC PHARMA has posted a net profit of Rs 3 bn (up 13.8% YoY). Sales on the other hand came in at Rs 13 bn (up 8.7% YoY). Read on for a complete analysis of ALEMBIC PHARMA's quarterly results.

ALEMBIC PHARMA Announces Quarterly Results (2QFY21); Net Profit Up 30.0% (Quarterly Result Update)

Oct 23, 2020 | Updated on Oct 23, 2020

For the quarter ended September 2020, ALEMBIC PHARMA has posted a net profit of Rs 3 bn (up 30.0% YoY). Sales on the other hand came in at Rs 15 bn (up 17.4% YoY). Read on for a complete analysis of ALEMBIC PHARMA's quarterly results.

ABBOTT INDIA Announces Quarterly Results (1QFY21); Net Profit Up 54.2% (Quarterly Result Update)

Aug 18, 2020 | Updated on Aug 18, 2020

For the quarter ended June 2020, ABBOTT INDIA has posted a net profit of Rs 2 bn (up 54.2% YoY). Sales on the other hand came in at Rs 11 bn (up 6.5% YoY). Read on for a complete analysis of ABBOTT INDIA's quarterly results.

ABBOTT INDIA Announces Quarterly Results (4QFY20); Net Profit Down 2.0% (Quarterly Result Update)

Jun 9, 2020 | Updated on Jun 9, 2020

For the quarter ended March 2020, ABBOTT INDIA has posted a net profit of Rs 1 bn (down 2.0% YoY). Sales on the other hand came in at Rs 10 bn (up 6.1% YoY). Read on for a complete analysis of ABBOTT INDIA's quarterly results.

ABBOTT INDIA Announces Quarterly Results (3QFY20); Net Profit Up 59.5% (Quarterly Result Update)

Feb 11, 2020 | Updated on Feb 11, 2020

For the quarter ended December 2019, ABBOTT INDIA has posted a net profit of Rs 2 bn (up 59.5% YoY). Sales on the other hand came in at Rs 11 bn (up 13.8% YoY). Read on for a complete analysis of ABBOTT INDIA's quarterly results.

More Views on News

Most Popular

Why Gold Hit Lower Circuit(Fast Profits Daily)

Jan 11, 2021

Were you shocked that bullion prices hit lower circuits on Friday on the MCX? Find out why it happened...

Time to Book Profits in Pharma Stocks(Fast Profits Daily)

Jan 15, 2021

In this video, I'll show you why it might be the right time to take money of the table in pharma stocks.

A Rare Chance to Invest in Potential Multibaggers in 2021(Profit Hunter)

Jan 11, 2021

Our ace stock picker is ready to capitalise on a big growth opportunity.

Smallcap Stocks: Your Best Bet for 2021 and Beyond(Profit Hunter)

Jan 15, 2021

The pandemic failed to thwart Richa's investing success formula for 2020.

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

ABBOTT INDIA SHARE PRICE


Jan 21, 2021 (Close)

TRACK ABBOTT INDIA

  • Track your investment in ABBOTT INDIA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

ABBOTT INDIA - DR. REDDYS LAB COMPARISON

COMPARE ABBOTT INDIA WITH

MARKET STATS